RecallDepth
Class III Terminated

Colchicine Tablets, USP 0.6 mg, Rx Only, a) 30 tablets per bottle, NDC 16714-0039-01, b) 100 tablets per bottle, NDC 16714-0039-02, Manufactured for: NorthStar Rx LLC., Memphis, TN 38141, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, c) 100 tablets per bottle, NDC 70710-1351-01, Manufactured by: Cadila Healthcare Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534.

This recall has been terminated (originally issued March 22, 2023).

Company
Zydus Pharmaceuticals (Usa) Inc
Recall Initiated
February 24, 2023
Posted
March 22, 2023
Recall Number
D-0467-2023
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
21,936/30 count bottles and 33,096/100 count bottles
Firm Location
Pennington, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed Impurities/Degradation Specifications: An out-of-specification (OOS) result was observed during release testing of one lot for a related substance, i.e. Beta-lumicolchicine.

Distribution

AZ, OH, MS.

Lot / Code Info

Lot #s: a) E203821, Exp. 05/2024; b) E203822, Exp. 05/2024, E206186, Exp. 10/2024; c) E203820, Exp. 05/2024.

More recalls by Zydus Pharmaceuticals (Usa) Inc

View all recalls by this company →

Other recent Class III Drug recalls